Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Common Equity: 2010-2025

Historic Common Equity for Nutex Health (NUTX) over the last 16 years, with Q3 2025 value amounting to $438.0 million.

  • Nutex Health's Common Equity rose 44906.2% to $438.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $438.0 million, marking a year-over-year increase of 44906.2%. This contributed to the annual value of $188.5 million for FY2024, which is 13832.93% up from last year.
  • Latest data reveals that Nutex Health reported Common Equity of $438.0 million as of Q3 2025, which was up 44906.2% from $336.9 million recorded in Q2 2025.
  • Nutex Health's Common Equity's 5-year high stood at $556.1 million during Q2 2022, with a 5-year trough of $66.3 million in Q1 2021.
  • Over the past 5 years, Nutex Health's median Common Equity value was $109.5 million (recorded in 2023), while the average stood at $172.8 million.
  • As far as peak fluctuations go, Nutex Health's Common Equity skyrocketed by 1699732.36% in 2021, and later tumbled by 8053.78% in 2023.
  • Quarter analysis of 5 years shows Nutex Health's Common Equity stood at $191.6 million in 2021, then plummeted by 37.19% to $120.3 million in 2022, then crashed by 34.26% to $79.1 million in 2023, then surged by 138.33% to $188.5 million in 2024, then soared by 132.34% to $438.0 million in 2025.
  • Its Common Equity was $438.0 million in Q3 2025, compared to $336.9 million in Q2 2025 and $255.3 million in Q1 2025.